Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

392 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agents.
Butler MC, Itotia PN, Sullivan JM. Butler MC, et al. Among authors: sullivan jm. Invest Ophthalmol Vis Sci. 2010 May;51(5):2705-20. doi: 10.1167/iovs.08-2862. Epub 2009 Oct 15. Invest Ophthalmol Vis Sci. 2010. PMID: 19834043 Free PMC article.
Bottlenecks in development of retinal therapeutic post-transcriptional gene silencing agents.
Sullivan JM, Yau EH, Taggart RT, Butler MC, Kolniak TA. Sullivan JM, et al. Vision Res. 2008 Feb;48(3):453-69. doi: 10.1016/j.visres.2007.09.011. Epub 2007 Oct 31. Vision Res. 2008. PMID: 17976683 Free PMC article. Review.
Development of lead hammerhead ribozyme candidates against human rod opsin mRNA for retinal degeneration therapy.
Abdelmaksoud HE, Yau EH, Zuker M, Sullivan JM. Abdelmaksoud HE, et al. Among authors: sullivan jm. Exp Eye Res. 2009 May;88(5):859-79. doi: 10.1016/j.exer.2008.11.018. Epub 2008 Dec 6. Exp Eye Res. 2009. PMID: 19094986 Free PMC article.
Fundus autofluorescence and photoreceptor cell rosettes in mouse models.
Flynn E, Ueda K, Auran E, Sullivan JM, Sparrow JR. Flynn E, et al. Among authors: sullivan jm. Invest Ophthalmol Vis Sci. 2014 Jul 11;55(9):5643-52. doi: 10.1167/iovs.14-14136. Invest Ophthalmol Vis Sci. 2014. PMID: 25015357 Free PMC article.
A Novel, Real-Time, In Vivo Mouse Retinal Imaging System.
Butler MC, Sullivan JM. Butler MC, et al. Among authors: sullivan jm. Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7159-68. doi: 10.1167/iovs.14-16370. Invest Ophthalmol Vis Sci. 2015. PMID: 26551329 Free PMC article.
A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.
Yau EH, Butler MC, Sullivan JM. Yau EH, et al. Among authors: sullivan jm. Exp Eye Res. 2016 Oct;151:236-55. doi: 10.1016/j.exer.2016.05.020. Epub 2016 May 25. Exp Eye Res. 2016. PMID: 27233447 Free PMC article.
Effects of Pathogenic Variations in the Human Rhodopsin Gene (hRHO) on the Predicted Accessibility for a Lead Candidate Ribozyme.
Froebel BR, Trujillo AJ, Sullivan JM. Froebel BR, et al. Among authors: sullivan jm. Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3576-3591. doi: 10.1167/iovs.16-20877. Invest Ophthalmol Vis Sci. 2017. PMID: 28715844 Free PMC article.
Systematic Screening, Rational Development, and Initial Optimization of Efficacious RNA Silencing Agents for Human Rod Opsin Therapeutics.
Yau EH, Taggart RT, Zuber M, Trujillo AJ, Fayazi ZS, Butler MC, Sheflin LG, Breen JB, Yu D, Sullivan JM. Yau EH, et al. Among authors: sullivan jm. Transl Vis Sci Technol. 2019 Dec 12;8(6):28. doi: 10.1167/tvst.8.6.28. eCollection 2019 Nov. Transl Vis Sci Technol. 2019. PMID: 31853424 Free PMC article.
392 results
Jump to page
Feedback